BioCatalystWatch
LQDAWorkspace / LQDA / OverviewCompany library
Price
Market cap
Next catalyst4Q 2026yutrepia · Trial initiationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

YUTREPIA

Approved

PreINDP1P2P3FilingApproved
YUTREPIA

YUTREPIA

PreINDP1P2P3FilingApproved
Upcoming / outlook

YUTREPIA

Upcoming / outlook

YUTREPIA

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

YUTREPIA

PreINDP1P2P3FilingApproved
Upcoming / outlook

YUTREPIA

Upcoming / outlook

YUTREPIA

Upcoming / outlook

YUTREPIA

Approved

PreINDP1P2P3FilingApproved
YUTREPIA

Other pipelines

L606

PreINDP1P2P3FilingApproved
L606

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

History / paused

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

LQDA SEC archive